OmniAb Inc.
Last updated September 27, 2026
Organization details
- Legal name
- OmniAb Inc.
- Former names
- Avista Public Acquisition Corp. II
- Ownership
- Public
- Status
- Active
- SIC code
- 8731 — Services-Commercial Physical & Biological Research
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Emeryville
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OABI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001846253
Board of directors
-
Carolyn R. Bertozzi · DirectorSince 2023
-
David F. Burgstahler · DirectorSince 2023
-
Jennifer R. Cochran · DirectorSince 2023
-
John L. Higgins · DirectorSince 2023
-
Joshua Alexander Tamaroff · DirectorSince 2023
-
Matthew W. Foehr · Director · President and CEOSince 2023
-
Philip J. Gotwals · DirectorSince 2025
-
Sarah Boyce · DirectorSince 2023
-
Steven C. Crouse · DirectorSince 2025
-
Steven Love · DirectorSince 2023
-
Sunil Patel · DirectorSince 2023
-
Thompson Dean · DirectorSince 2023
Chief executives
Matthew W. Foehr
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
69.0%
-
98.0%
Board connections
5 of this board's directors also sit on 7 other boards.
- via Carolyn R. Bertozzi
- via Sarah Boyce
- via John L. Higgins
- via Philip J. Gotwals
- via Sarah Boyce
- via Carolyn R. Bertozzi
- via Matthew W. Foehr
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $107,707
- 2 purchases by 1 insider
- Sold, last 12 months
- $283,036
- 12 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Carolyn R. Bertozzi Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Jennifer R. Cochran Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Steven C. Crouse Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Philip J. Gotwals Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | John L. Higgins Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Steven Love Director | Option exercise | +20,000 | — | — |
| Apr 21, 2026 | Philip J. Gotwals Director | Option exercise | +13,333 | — | — |
| Apr 21, 2026 | Steven C. Crouse Director | Option exercise | +13,333 | — | — |
| Apr 7, 2026 | Matthew W. Foehr Director, Officer (President and CEO) | Option exercise | +36,459 | — | — |
| Apr 7, 2026 | Kurt A. Gustafson Officer (Executive VP, Finance and CFO) | Option exercise | +13,542 | — | — |
| Apr 7, 2026 | Berkman Charles S Officer (Chief Legal Officer) | Option exercise | +13,542 | — | — |
| Apr 7, 2026 | Matthew W. Foehr Director, Officer (President and CEO) | Open-market sale | −19,244 | $1.49 | $28,674 |
| Apr 7, 2026 | Kurt A. Gustafson Officer (Executive VP, Finance and CFO) | Open-market sale | −6,913 | $1.49 | $10,300 |
| Apr 7, 2026 | Berkman Charles S Officer (Chief Legal Officer) | Open-market sale | −7,157 | $1.49 | $10,664 |
| Feb 18, 2026 | Berkman Charles S Officer (Chief Legal Officer) | Option exercise | +18,750 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.